3+ hour, 49+ min ago  (364+ words) Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest…...

4+ hour, 34+ min ago  (225+ words) Jun Li further remarked, "Studying previously overlooked populations frequently uncovers biological insights that challenge prevailing assumptions and enrich our comprehension of cancer." By capturing the invisible intricacies of tumor biology in Native American women, this research paves the way for…...

1+ day, 5+ hour ago  (543+ words) Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in g BRCA-mutated HER2-Negative Breast Cancer Key milestone positions ART6043 as the most advanced Pol-theta inhibitor in clinical development; the potentially first-in-class program is supported by…...

10+ hour, 10+ min ago  (259+ words) The Food and Drug Administration (FDA) has expanded the approval of Enhertu" (fam-trastuzumab deruxtecan-nxki; T-DXd) to include 2 new human epidermal growth factor receptor (HER2)-positive early breast cancer indications. Enhertu followed by a taxane, trastuzumab, and pertuzumab (THP) has been approved…...

1+ hour, 54+ min ago  (124+ words) Jamie Vaughn, founder and president of Test Those Breasts, Inc. , is hosting a free community breast health class Tuesday, June 2 that focuses on early detection, breast health awareness and reaching. .. RENO, Nev. (KOLO) - Jamie Vaughn, founder and president of Test…...

3+ hour, 46+ min ago  (386+ words) SAN ANTONIO " Three FDA breakthrough approvals for breast cancer treatments presented at the San Antonio Breast Cancer Symposium are offering new hope for patients battling both early and late-stage breast cancer. All three drugs have been used in clinical trials…...

9+ hour, 28+ min ago  (610+ words) I'M A Celeb star Beverley Callard has revealed she's suffered a blow in her breast cancer battle and admitted the news was "not what I wanted to hear. The actress, 69, told how medics were "a little concerned by recent test…...

3+ week, 1+ day ago  (225+ words) About DENALI Clinical Trial "DENALI is a multi-part Phase 2 registration-intended clinical trial (NCT05128825) studying azenosertib in PROC patients. Part 1b enrolled patients with PROC regardless of Cyclin E1 protein expression, all treated at 400mg QD 5: 2. Part 2 is prospectively enrolling PROC patients with Cyclin E1 protein…...

4+ hour, 9+ min ago  (307+ words) A Brewer man has donated $10 million to establish a local genomics and cancer research center in honor of his wife who died from cancer. The Jim and Cathy Gero Center for Genomics and Advanced Therapies will be located at the…...

8+ hour, 46+ min ago  (706+ words) SAN FRANCISCO, May 27, 2026--Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile Oops, something went wrong Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile Integrated analyses show higher tumor exposure than doxorubicin and…...